Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years

医学 结直肠癌 全直肠系膜切除术 累积发病率 外科 放化疗 入射(几何) 临床终点 阶段(地层学) 随机对照试验 癌症 放射治疗 内科学 古生物学 物理 移植 光学 生物
作者
Rolf Sauer,Torsten Liersch,Susanne Merkel,Rainer Fietkau,Werner Hohenberger,Clemens F. Hess,Heinz Becker,Hans-Rudolf Raab,Marie-Therese Villanueva,Helmut Witzigmann,Christian Wittekind,Tim Beißbarth,Claus Rödel
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:30 (16): 1926-1933 被引量:1828
标识
DOI:10.1200/jco.2011.40.1836
摘要

Purpose Preoperative chemoradiotherapy (CRT) has been established as standard treatment for locally advanced rectal cancer after first results of the CAO/ARO/AIO-94 [Working Group of Surgical Oncology/Working Group of Radiation Oncology/Working Group of Medical Oncology of the Germany Cancer Society] trial, published in 2004, showed an improved local control rate. However, after a median follow-up of 46 months, no survival benefit could be shown. Here, we report long-term results with a median follow-up of 134 months. Patients and Methods A total of 823 patients with stage II to III rectal cancer were randomly assigned to preoperative CRT with fluorouracil (FU), total mesorectal excision surgery, and adjuvant FU chemotherapy, or the same schedule of CRT used postoperatively. The study was designed to have 80% power to detect a difference of 10% in 5-year overall survival as the primary end point. Secondary end points included the cumulative incidence of local and distant relapses and disease-free survival. Results Of 799 eligible patients, 404 were randomly assigned to preoperative and 395 to postoperative CRT. According to intention-to-treat analysis, overall survival at 10 years was 59.6% in the preoperative arm and 59.9% in the postoperative arm (P = .85). The 10-year cumulative incidence of local relapse was 7.1% and 10.1% in the pre- and postoperative arms, respectively (P = .048). No significant differences were detected for 10-year cumulative incidence of distant metastases (29.8% and 29.6%; P = .9) and disease-free survival. Conclusion There is a persisting significant improvement of pre- versus postoperative CRT on local control; however, there was no effect on overall survival. Integrating more effective systemic treatment into the multimodal therapy has been adopted in the CAO/ARO/AIO-04 trial to possibly reduce distant metastases and improve survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Disguise完成签到,获得积分10
1秒前
Young4399完成签到 ,获得积分10
1秒前
火星上宛秋完成签到 ,获得积分10
2秒前
2秒前
2秒前
量子星尘发布了新的文献求助10
2秒前
szh123完成签到 ,获得积分10
3秒前
Luke发布了新的文献求助10
5秒前
mauve完成签到 ,获得积分10
5秒前
丽丽完成签到,获得积分10
9秒前
敏感笑槐完成签到 ,获得积分10
10秒前
Luke完成签到,获得积分10
10秒前
得鹿梦鱼完成签到,获得积分10
11秒前
嗝嗝完成签到,获得积分10
13秒前
Perry应助科研通管家采纳,获得30
13秒前
13秒前
今后应助水晶茶杯采纳,获得10
13秒前
peterlzb1234567完成签到,获得积分10
15秒前
natsu401完成签到 ,获得积分10
18秒前
mmddlj完成签到 ,获得积分10
18秒前
健康的雁凡完成签到,获得积分10
18秒前
稳重完成签到 ,获得积分10
20秒前
23秒前
haiqi完成签到,获得积分20
27秒前
白智妍发布了新的文献求助10
28秒前
王叮叮完成签到,获得积分10
29秒前
jeronimo完成签到,获得积分10
30秒前
30秒前
pcr163应助大橙子采纳,获得150
33秒前
李燕发布了新的文献求助10
35秒前
道友等等我完成签到,获得积分0
35秒前
狂野乌冬面完成签到 ,获得积分10
39秒前
xinglin完成签到 ,获得积分10
41秒前
清浅完成签到 ,获得积分10
41秒前
43秒前
44秒前
科奇完成签到,获得积分10
44秒前
可玩性完成签到 ,获得积分10
45秒前
要减肥岩完成签到,获得积分10
47秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038184
求助须知:如何正确求助?哪些是违规求助? 3575908
关于积分的说明 11373872
捐赠科研通 3305715
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022